$2 million upon announcement of the Company entering into a licensing arrangement with a pharmaceutical company for any of the Company’s clinical assets that will include an initial payment to the Company of an amount in the double-digits millions of dollars.
And in detail in the 8-K:
(c) “BD Agreement” means a significant licensing arrangement with a pharmaceutical company that will include an initial (“up-front”) payment to the Company in an amount in the double-digits millions of dollars and will arrange for such pharmaceutical company to undertake the continuing development of the Company’s Brilacidin compound in the indication of Oral Mucositis, including the conducting and funding of clinical trials aiming towards the filing of an NDA.
THAT MY FRIEND IS PRETTY DETAILED.........I'D SAY THEY ARE JUST WAITING TO SEE IF BTD IS GRANTED AND THE DEAL IS DONE!
News 
Market Data 
Discover 
